Crossmark

Towards mission-driven investment in new antimicrobials? What role for Chinese strategic industrial financing vehicles in responding to the challenge of antimicrobial resistance?

Crossref DOI link: https://doi.org/10.1186/s12992-024-01030-2

Published Online: 2024-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Husain, Lewis http://orcid.org/0000-0001-9315-8779
Hu, Yajing

Huang, Yangmu
Funding

Funding for this research was provided by:

Medical Research Council (MR/S014934/1)
License Information

Text and Data Mining valid from 2024-03-26

Version of Record valid from 2024-03-26
More Information

Article History

Received: 31 October 2023

Accepted: 13 March 2024

First Online: 26 March 2024

Declarations

:

: Ethical approval was granted by the Institutional Review Board of the Institute of Development Studies. Informed consent was requested of all interviewees when invited to participate in interviews, and standard protocols introducing the study, and consent forms including a statement of the right to withdraw, were used. Anonymity was granted as standard.

: All authors have approved the manuscript for submission.

: The authors declare they have no competing interests.

Document is current

Any future updates will be listed below